http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108283640-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418 |
| filingDate | 2017-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108283640-B |
| titleOfInvention | Aromatic ester compound for preparing medicine for resisting ADV-7 virus |
| abstract | The invention discloses an aromatic ester compound for preparing a medicine for resisting ADV-7 virus, wherein the aromatic ester compound has a chemical structural formula as follows: the compound of (1) can inhibit cytopathic effect (CPE) generated by ADV-7 on a host cell RD, enhance cell survival rate, reduce the yield of progeny virus and inhibit host cell apoptosis caused by ADV-7 infection by aromatic ester compounds WY209 and WY210 through an ADV-7 resistant activity research experiment on the aromatic ester compounds WY209 and WY210, and can be used for preparing the drug for resisting the ADV-7 virus. |
| priorityDate | 2017-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.